Recently, Pizzini et al. studied mTORC1 activation in a cohort of 58 patients with sarcoidosis, and demonstrated that all patients had a positive activation of S6K [11], which is not in concordance with the 33% of patients described by Linke et al. The gene discussed is RPS6KB1; the disease is sarcoidosis.